tiprankstipranks
Trending News
More News >
Pigeon Corporation (JP:7956)
:7956
Japanese Market

Pigeon Corporation (7956) AI Stock Analysis

Compare
3 Followers

Top Page

JP:7956

Pigeon Corporation

(7956)

Select Model
Select Model
Select Model
Outperform 77 (OpenAI - 5.2)
Rating:77Outperform
Price Target:
¥1,856.00
▲(15.17% Upside)
Action:UpgradedDate:02/18/26
The score is driven primarily by strong financial performance—especially the very low leverage balance sheet and steady profitability—partly offset by uneven growth and softer recent cash conversion. Technical signals are broadly neutral, and valuation is supported by a high dividend yield but moderated by a mid-to-higher P/E.
Positive Factors
Conservative balance sheet
Very low leverage and steadily rising equity give the company durable financial flexibility. This conservative capital structure supports investment in R&D and distribution, sustains dividend policy in downturns, and reduces refinancing and credit risk over a multi‑month horizon.
Stable high margins
Consistently strong gross and operating margins reflect pricing power from branded baby and maternity products and efficient manufacturing. Margin resilience supports predictable profitability, funds reinvestment, and cushions earnings against modest revenue volatility over several quarters.
Recurring, brand-driven revenue
Core sales come from repeat-purchase consumables and branded infant care items, creating predictable demand and customer stickiness. This recurring revenue base eases forecasting, supports shelf presence and e‑commerce channels, and underpins long‑run cash generation.
Negative Factors
Uneven revenue growth
Revenue growth has been modest and inconsistent since 2020, limiting the company’s ability to compound scale benefits. This uneven top-line trend raises uncertainty about sustaining investment in expansion and may constrain medium‑term margin expansion and operating leverage.
Weakened cash conversion
Operating cash flow lagging reported earnings and uneven free cash flow indicate working capital or timing variability. Lower cash conversion reduces internal funding for capex, M&A, or shareholder returns and makes the business more sensitive to short‑run balance sheet swings.
Returns and margins below prior peak
Returns on equity and margins remain respectable but below earlier highs, suggesting some erosion in profitability or mix shifts. Recovering past peak efficiency may require structural improvements in product mix, pricing, or cost base and is not assured over the next few quarters.

Pigeon Corporation (7956) vs. iShares MSCI Japan ETF (EWJ)

Pigeon Corporation Business Overview & Revenue Model

Company DescriptionPigeon Corporation manufactures, sells, imports, and exports baby and child-care products, maternity items, women's care products, home healthcare products, and elder care products in Japan and internationally. The company operates in four segments: Japan Business, China Business, Singapore Business, and Lansinoh Business. It offers breastfeeding, weaning, skincare, women's care, and large-sized products for babies, as well as other products for babies and mothers. The company also provides child-rearing support, babysitter dispatch, event child-care, and preschool education services; and operates child-minding facilities and daycare centers. In addition, it offers elder care and anti-aging products, and elder care support services; and baby and mother related care products, such as nursing bottles and nipples, toiletries, and skincare products. Pigeon Corporation markets its products under the Pigeon and Lansinoh brands. The company was formerly known as Pigeon Honyuki Honpo Corporation and changed its name to Pigeon Corporation in 1966. Pigeon Corporation was founded in 1949 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyPigeon Corporation generates revenue through the sale of its consumer goods, primarily in the baby and maternal care segments. The company operates on a B2C model, selling directly to consumers through retail partnerships, e-commerce platforms, and its own online store. Key revenue streams include sales of baby feeding products, hygiene items, and nursing accessories. Pigeon also benefits from established relationships with major retailers and distributors, which help in expanding its market reach. Additionally, the company invests in research and development to innovate and enhance its product offerings, which helps sustain its competitive edge and drive sales growth.

Pigeon Corporation Financial Statement Overview

Summary
Strong overall financial quality led by an exceptionally conservative balance sheet (very low leverage, rising equity). Profitability is healthy with solid, stable margins, but revenue growth has been modest/uneven and recent cash conversion vs. earnings has softened, keeping the score below top-tier.
Income Statement
77
Positive
Revenue has resumed growth (2025 up ~2.4% after a near-flat 2024), but the longer-term trend shows volatility since 2020. Profitability remains healthy with consistently strong gross margins (~47–50%) and solid operating margins (~12–16%), though margins have generally stepped down from 2020–2021 peaks. Net margin has been stable around ~7.9–9.4% in recent years, indicating resilient earnings power but limited recent acceleration.
Balance Sheet
92
Very Positive
The balance sheet is a major strength: leverage is extremely low, with debt-to-equity consistently around ~0.02 and debt declining overall versus earlier years. Equity has steadily grown, supporting a strong capital base and financial flexibility. Returns on equity are respectable (roughly ~9.6–11.9% in 2021–2024) but below the 2020 high, suggesting profitability is solid but not at peak efficiency.
Cash Flow
74
Positive
Cash generation is generally solid, with free cash flow positive each year and 2025 still producing meaningful free cash flow. However, cash conversion has softened recently: operating cash flow relative to earnings is below 1.0 in 2024–2025, and free cash flow relative to net income is less consistent (notably lower in 2021–2023 before improving). Free cash flow growth has been uneven across the period, pointing to some variability in working capital and/or investment spending.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue106.59B109.17B104.17B94.46B94.92B93.08B
Gross Profit53.58B54.84B51.37B45.45B44.83B44.07B
EBITDA17.42B17.76B17.82B16.33B17.14B17.77B
Net Income9.42B8.57B8.37B7.42B8.58B8.79B
Balance Sheet
Total Assets105.40B110.09B108.31B100.44B101.73B98.04B
Cash, Cash Equivalents and Short-Term Investments34.07B39.61B39.20B34.36B34.28B35.22B
Total Debt4.89B1.36B1.77B1.90B2.06B1.94B
Total Liabilities24.75B24.20B23.70B19.35B21.78B21.23B
Stockholders Equity78.10B82.92B81.14B77.58B76.69B73.88B
Cash Flow
Free Cash Flow0.0010.26B12.21B8.87B7.65B5.00B
Operating Cash Flow0.0013.06B14.28B14.52B13.21B10.89B
Investing Cash Flow0.00-3.14B-1.14B-5.47B-5.66B-5.59B
Financing Cash Flow0.00-10.82B-10.64B-10.26B-9.67B-8.69B

Pigeon Corporation Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1611.50
Price Trends
50DMA
1632.63
Positive
100DMA
1636.35
Positive
200DMA
1679.38
Positive
Market Momentum
MACD
18.58
Negative
RSI
69.36
Neutral
STOCH
76.53
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7956, the sentiment is Positive. The current price of 1611.5 is below the 20-day moving average (MA) of 1655.85, below the 50-day MA of 1632.63, and below the 200-day MA of 1679.38, indicating a bullish trend. The MACD of 18.58 indicates Negative momentum. The RSI at 69.36 is Neutral, neither overbought nor oversold. The STOCH value of 76.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7956.

Pigeon Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥1.96T28.6710.79%3.47%-1.56%-1.15%
77
Outperform
¥206.31B24.074.66%11.38%79.21%
76
Outperform
¥498.97B18.439.77%1.73%2.18%60.81%
75
Outperform
¥310.02B14.217.40%2.30%3.75%3.77%
71
Outperform
¥566.93B16.0113.22%1.53%18.35%31.87%
70
Outperform
¥3.02T25.6411.70%2.41%4.62%47.68%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7956
Pigeon Corporation
1,724.50
202.69
13.32%
JP:4452
Kao
6,674.00
276.67
4.32%
JP:4912
Lion
1,838.50
125.37
7.32%
JP:8283
Paltac
5,058.00
1,169.11
30.06%
JP:4527
Rohto Pharmaceutical Co
2,442.00
313.40
14.72%
JP:8113
Unicharm
1,069.50
-33.72
-3.06%

Pigeon Corporation Corporate Events

Pigeon Revamps Board and Elevates Strategy Chief as Director in Global Reorganization
Feb 13, 2026

Pigeon Corporation has announced board nominations and senior personnel changes effective March 27, 2026, including the reappointment of President and CEO Ryo Yano and several incumbent inside and outside directors. The board has also nominated Chief Strategy Officer Nobuo Takubo as a new director, citing his extensive background in corporate strategy, M&A, and group-wide planning as critical to supporting sustainable growth and enhancing medium- to long-term corporate value.

The company will see the retirement of director and executive officer Kevin Vyse-Peacock and outside director Eriko Yamaguchi, while maintaining four independent outside directors who will continue to serve as key governance anchors. In a parallel move, Pigeon is restructuring its international organization by renaming the “Lansinoh Business Unit Chief Executive Officer” role to “Americas & Europe Business Unit Chief Executive Officer” and assigning Group Executive Officer Julie Talbot to lead this broader mandate, underscoring a strategic focus on integrated oversight of its Western markets.

The most recent analyst rating on (JP:7956) stock is a Buy with a Yen2000.00 price target. To see the full list of analyst forecasts on Pigeon Corporation stock, see the JP:7956 Stock Forecast page.

Pigeon Extends and Upsizes Performance-Linked Stock Plan for Directors
Feb 13, 2026

Pigeon Corporation plans to continue and partially revise its performance-linked stock remuneration program for internal directors, subject to shareholder approval at the March 27, 2026 general meeting. The program, structured as a Board Incentive Plan trust introduced in 2019, ties stock-based compensation to medium- and long-term business performance and corporate value.

The revised plan will extend the trust period by three fiscal years through 2028, increase the proportion of stock-based pay for directors, and raise the maximum number of shares to be granted while maintaining zero dilution by purchasing shares on the market. Performance-linked coefficients will be made more sensitive, rising to a 0–200% range based on financial and key issue indicators aligned with Pigeon’s 9th Medium-Term Business Plan, strengthening the link between management rewards, strategic execution, and shareholder interests.

The most recent analyst rating on (JP:7956) stock is a Buy with a Yen2000.00 price target. To see the full list of analyst forecasts on Pigeon Corporation stock, see the JP:7956 Stock Forecast page.

Pigeon Posts Steady 2025 Profit Growth and Keeps High Dividend as It Guides for Further Gains in 2026
Feb 13, 2026

Pigeon Corporation reported consolidated net sales of ¥109.2 billion for the year ended December 31, 2025, up 4.8% year on year, with operating income rising 8.4% to ¥13.2 billion and net income attributable to owners of the parent increasing 2.4% to ¥8.6 billion. Profitability metrics such as operating margin and return on equity remained solid, while total assets and equity ratio both improved, supported by positive operating cash flow and stable cash and cash equivalents.

The company maintained its annual dividend at ¥76 per share, implying a high payout ratio slightly above 100%, underscoring a continued emphasis on shareholder returns despite only modest earnings growth. For fiscal 2026, Pigeon forecasts further gains, guiding to a 4.0% increase in net sales and a 6.7% rise in net income, which, if achieved, would reinforce its stable earnings profile and support its positioning as a steady income stock for investors.

The most recent analyst rating on (JP:7956) stock is a Buy with a Yen2000.00 price target. To see the full list of analyst forecasts on Pigeon Corporation stock, see the JP:7956 Stock Forecast page.

Pigeon Sets Ninth Medium-Term Plan to Drive Corporate Value Through 2028
Feb 13, 2026

Pigeon Corporation has formulated its Ninth Medium-Term Business Plan, setting a strategic roadmap for the three fiscal years from 2026 through 2028 aimed at further enhancing corporate value. The company will unveil comprehensive details of the plan, including its key initiatives and financial goals, at its February 13, 2026 financial results briefing, with materials to be made available on its investor relations website, signaling a structured approach to medium-term strategy and stakeholder communication.

The announcement underscores management’s focus on disciplined planning and transparency as it enters a new three-year cycle, which may influence investor expectations around growth and profitability. While specific targets were not disclosed in this notice, the emphasis on corporate value enhancement and the timing alongside financial results suggest that Pigeon is positioning itself for a potentially more proactive phase in capital markets and operational execution.

The most recent analyst rating on (JP:7956) stock is a Buy with a Yen2000.00 price target. To see the full list of analyst forecasts on Pigeon Corporation stock, see the JP:7956 Stock Forecast page.

Pigeon Launches Voluntary Recall of Habinurse Nursing Care Mist, Sees Minimal Earnings Impact
Feb 12, 2026

Pigeon Corporation has initiated a voluntary recall of 10,290 units of its nursing care product “Habinurse Rakuraku Oshiri Kirei Mist” produced between March and October 2025, after discovering that cracks in some spray tip components could cause leakage or unintended spray direction. Although no health damage has been reported and the company expects the impact on consolidated earnings to be negligible, Pigeon has asked customers to stop using affected items immediately and pledged to strengthen quality control to prevent recurrence, underscoring its emphasis on safety and risk management in its nursing care portfolio.

The recall highlights Pigeon’s effort to protect brand trust and reassure customers and business partners in the competitive nursing care market, where product reliability is critical for reputation and long-term demand. By moving quickly to withdraw the defective lots and publicly apologize, the company aims to limit operational disruption and maintain its position as a responsible supplier of nursing and elder care products, while signaling to stakeholders that improved quality assurance will be a priority going forward.

The most recent analyst rating on (JP:7956) stock is a Buy with a Yen2000.00 price target. To see the full list of analyst forecasts on Pigeon Corporation stock, see the JP:7956 Stock Forecast page.

Pigeon Corporation Announces Strategic Reorganization Ahead of 2026 Business Plan
Dec 9, 2025

Pigeon Corporation announced a significant reorganization and personnel transfers to prepare for its upcoming Medium-Term Business Plan starting in 2026. The changes aim to enhance global market presence, improve profitability, and strengthen governance by restructuring the executive organization and introducing new roles such as Group Executive Officers. This strategic move is expected to streamline operations, optimize resources, and clarify responsibilities, potentially impacting the company’s market positioning and stakeholder engagement.

The most recent analyst rating on (JP:7956) stock is a Hold with a Yen1753.00 price target. To see the full list of analyst forecasts on Pigeon Corporation stock, see the JP:7956 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026